Skip to content

AKV PHARMA

Active Private limited company (pre-2019)founded 2015active for 10 yearsKoolskampstraat 69, 8740 PittemKBO/BCE: BE 0644.617.062 subsidiary of

Lifetime

10 annual accounts with figures on one time axis
peak of €220,561 in 2020
€40,416▲ 15.2%
lowest -€130 in 2017
€25,201▲ 196%
peak of €98,330 in 2020
€52,420▲ 92.6%
€6,144▼ 94.8%
peak of 2.3 FTE in 2016
-not published
Board2 names since 2015
2 directors and 1 other
Documentsfilings and deeds
23-06-202638 days before the deadline
2025micro format
Gross margin from €35,082 to €40,416Result from €8,515 to €25,201Equity from €27,219 to €52,420Debts from €117,618 to €6,144Cash from €40,795 to €57,661

Key points

from the 2025 annual accounts

Equity

€52,420 from €98,330 in 2020

Equity fell by 47% in 5 years.

Turnover

≈ €180,000 estimated

The accounts state no turnover.

Liquidity

9.53 was 1.16 in 2024

Short-term debts fell from €110,921 to €6,144.

Filings

10 annual accounts since 2016
AprilJune31 JulyOctober20202025

The last five annual accounts were filed 27 to 41 days before the end of the period.

Board

1 joined · 1 left

Board changed. Latest change 13-05-2026 · 1 in office.

Position in the sector

89.5%

Higher solvency than 93% of companies in retail trade. Sector median 33.3% · 25,338 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,726 companies had the same profile as AKV PHARMA has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,726 companies, not a prediction for AKV PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, , since 01-04-2026
  • 100%score equity €354,554 (2026) · annual accounts 31-03-2026 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0644617062
Registered office moved from Bruges to Pittem The registered office moved from Fazantenlaan 13, 8200 Brugge to Koolskampstraat 69, 8740 Pittem · resigns as director · appointed as director · General meeting of 01-04-2026 · Gazette deed
New director appointed, resigned · Director discharge: · General meeting of 07-03-2023 · Gazette deed
Registered office moved to Bruges The registered office moved to Fazantenlaan 13, 8000 Brugge, België · Board meeting of 30-03-2020 · Gazette deed
All 21 events

Comparable companies

same main activity, similar in size and age
Company
AKV PHARMA Pittem €58,563 €40,416 89.5% -
SoBayFRo Tournai €54,756 €41,082 30.9% -
PharmaSi Maasmechelen €58,595 €44,166 89.2% -
VANGHELUWE L. Ninove €65,040 €53,334 83.2% -
VANFLETEREN PIETER Antwerp €52,894 €36,548 69.8% -
KameleonPharma Wellen €70,327 €31,928 81.4% -
NIEMEGEERS KAROLIEN Bonheiden €61,719 €36,058 30.1% -

These companies have the same main activity as AKV PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €52,900 and €70,300, founded between 2015 and 2018.

Official details

Source: KBO
Status
Active since 17-12-2015Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.249.127.1228460 Oudenburg, since 17-12-2015
Financial year end
31 December
Peppol
Reachable since 13-07-2026
Company details

Annual accounts 2025

€58,563▼ 59.6%
Filing
Filed on 23-06-2026, 38 days before the end of the filing period
Financials

Insights on AKV PHARMA

AKV PHARMA files the micro format. That format states no turnover. The gross margin fell from €190,451 in 2016 to €40,416 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about AKV PHARMA

What is the company number of AKV PHARMA?
The company number of AKV PHARMA is 0644.617.062. The VAT number is the same number with BE in front: BE 0644.617.062.
Where is AKV PHARMA based?
The registered office is at Koolskampstraat 69, 8740 Pittem.Company details
What does AKV PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of AKV PHARMA?
AKV PHARMA is a private limited company (pre-2019) (BVBA).
When was AKV PHARMA founded?
AKV PHARMA was founded on 17-12-2015.
Is AKV PHARMA still active?
Yes, AKV PHARMA is an active enterprise in the KBO register.
How many employees does AKV PHARMA have?
AKV PHARMA had an average of 1.9 full-time equivalents in financial year 2020, according to the filed annual accounts.Financials
What is the turnover of AKV PHARMA?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €40,416 and 56 comparable companies (NACE 477). It probably lies between €100,000 and €330,000.
Is AKV PHARMA profitable?
In financial year 2025, AKV PHARMA made a profit of €25,201.
Where can I find the annual accounts of AKV PHARMA?
AKV PHARMA filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of AKV PHARMA due?
AKV PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.